Allergy Partners Therapeutics Earns URAC Accreditation
by Allergy Partners
August 11, 2026

A Commitment to high-quality, patient-centered allergy and asthma care
ASHEVILLE, NC – Allergy Partners Therapeutics, the pharmacy division of Allergy Partners Management, LLC, announced it has been awarded full accreditation under the Utilization Review Accreditation Commission (URAC), a nationally recognized independent leader in health care accreditation, Specialty Pharmacy 6.0 Program.
URAC Specialty Pharmacy standards are among the most rigorous in the industry, designed to ensure that accredited organizations demonstrate excellence in quality, safety, clinical expertise, and patient-centered care.
“URAC accreditation is a powerful validation of the way we care for patients,” said William McCann, M.D., CEO at Allergy Partners. “The ordering and use of specialty medications for asthma and allergic disease is complex, and patients rely on us to guide them safely through their journey.”
URAC’s Specialty Pharmacy 6.0 accreditation confirms that Allergy Partners Therapeutics:
- Meets nationally recognized quality standards through independent, third‑party review of its operations and clinical programs.
- Implements validated processes and outcomes that support safe, clinically appropriate, and efficient use of specialty medications.
- Delivers patient-centered, coordinated care for asthma and allergic conditions, working closely with physicians and care teams across the Allergy Partners practice.
“Achieving URAC Specialty Pharmacy accreditation reflects the dedication of our pharmacy and compliance teams,” said Kelly Hoots, PharmD, Pharmacy Manager for Allergy Partners Therapeutics. “We built our programs with one goal in mind: to make specialty therapies as safe, accessible, and manageable as possible for patients and the clinicians who care for them.”
As a URAC-accredited specialty pharmacy, Allergy Partners Therapeutics is positioned to serve as a trusted partner and navigator between patients and payer organizations while improving access to high-quality allergy and asthma medications. By demonstrating rigorous compliance with national best-practice standards, Allergy Partners Therapeutics reinforces the integrity and reliability of its clinical programs.
“This milestone reflects not only the strength of our pharmacy, but the culture of quality that runs throughout Allergy Partners,” Dr. McCann added. “Our teams work carefully and thoughtfully, always with the patient at the center. URAC’s accreditation affirms that commitment and sets the stage for continued innovation in how we deliver care.”
###
About Allergy Partners and Allergy Partners Therapeutics Allergy Partners Management, LLC is the nation’s largest and most trusted single-specialty allergy, asthma, and immunology practice, serving communities through more than 113 clinics across 20 states for almost 50 years. Led by board-certified allergist-immunologists, Allergy Partners is dedicated to improving patients’ quality of life through compassionate, personalized care and the advancement of allergy and asthma treatment. Its specialty pharmacy division, Allergy Partners Therapeutics, extends this commitment by integrating clinical care and pharmacy services to provide advanced medication management and coordinated care for complex allergic and asthma
